Gotham Asset Management LLC Acquires 9,615 Shares of STERIS plc (NYSE:STE)

Gotham Asset Management LLC boosted its holdings in shares of STERIS plc (NYSE:STEFree Report) by 10.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 103,163 shares of the medical equipment provider’s stock after buying an additional 9,615 shares during the period. Gotham Asset Management LLC owned approximately 0.10% of STERIS worth $21,206,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the business. Norges Bank purchased a new stake in shares of STERIS in the fourth quarter worth approximately $238,836,000. Raymond James Financial Inc. purchased a new stake in STERIS in the 4th quarter valued at $223,987,000. Franklin Resources Inc. lifted its stake in STERIS by 45.1% during the 4th quarter. Franklin Resources Inc. now owns 1,216,821 shares of the medical equipment provider’s stock valued at $250,130,000 after acquiring an additional 378,252 shares in the last quarter. Wellington Management Group LLP boosted its holdings in STERIS by 4,534.6% during the 4th quarter. Wellington Management Group LLP now owns 219,032 shares of the medical equipment provider’s stock worth $45,024,000 after acquiring an additional 214,306 shares during the last quarter. Finally, D. E. Shaw & Co. Inc. bought a new stake in shares of STERIS in the 4th quarter worth $37,243,000. 94.69% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the stock. Stephens raised shares of STERIS to a “strong-buy” rating in a research report on Thursday, May 1st. Piper Sandler boosted their target price on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research report on Monday, April 7th. Finally, JMP Securities reissued a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a research report on Thursday, April 10th. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus price target of $258.75.

Check Out Our Latest Stock Report on STERIS

STERIS Price Performance

STERIS stock opened at $226.54 on Friday. The business’s 50 day simple moving average is $223.40 and its 200 day simple moving average is $218.87. STERIS plc has a 12 month low of $200.98 and a 12 month high of $248.24. The company has a market cap of $22.26 billion, a price-to-earnings ratio of 48.10 and a beta of 0.96. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32.

STERIS (NYSE:STEGet Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Sell-side analysts forecast that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 26th. Stockholders of record on Tuesday, June 10th will be given a $0.57 dividend. This represents a $2.28 annualized dividend and a dividend yield of 1.01%. The ex-dividend date of this dividend is Tuesday, June 10th. STERIS’s dividend payout ratio (DPR) is currently 48.41%.

STERIS Profile

(Free Report)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Featured Articles

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STEFree Report).

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.